Clinical IT management consulting firm Emanate Life Sciences joins forces with Hewlett Packard and ERT to host its first session of Collaborations in Clinical Research, a panel discussion and networking event for medical device, biotech and pharmaceutical professionals. Registration for this event is free of charge.
The event addresses the topic of Risk Based Monitoring: What works? What doesn’t work? and takes place June 27th, 2017 at HP offices in Palo Alto, CA. Panelists include subject matter experts from ClinPros, Hart Clinical Consultants, and Kestrel Biologic Inc.
Collaborations in Clinical Research is a San Francisco Bay Area networking event that discusses a variety of topics related to clinical operations, clinical data management and medical affairs. Attendees of the event will include executives, management and clinical research professionals who wish to expand their knowledge or network. The event is free of charge, includes food and drinks, a panel discussion, and a networking session.
The panel will discuss Risk Based Monitoring: What works? What does not work? Panelists will include clinical project managers, clinical research associates, clinical data managers, site research coordinators and software providers. During this session, clinical research professionals will discuss recently released E6 R2 Good Clinical Practice guidelines and its impact on risk-based monitoring, including key risk indicators, monitoring approaches, tools and technologies available. Full event description.
Panelists: Click here to read their bios
Lorne Cheeseman / Chief Executive Officer at Kestrel Biologic Inc.
Candace Elek, M.S. / President at ClinPros
Jim Hart, RN, CCRA / Chief Executive Officer at Hart Clinical Consultants
Event details: Click here to register
June 27th, 2017
5.30PM – 8.30PM
HP, 1501 Page Mill Rd, Building 5, Palo Alto, CA 94304